Stock market news live updates: S&P 500 drops to the lowest level in a month as tech rout continues

In This Article:

Stocks fell Tuesday, with the three major indices logging their third straight sessions of losses as last week’s tech-led selloff rolled on.

[Click here to read what’s moving markets heading into Wednesday, September 9]

Shares of mega-cap technology stocks extended declines as investors continued to rotate away from the equity leaders of the past several months. Shares of Facebook (FB), Amazon (AMZN) and Apple (AAPL) were each off by at least 4%. Tesla (TSLA) shares slid by the most ever after the company was bypassed for S&P 500 inclusion, and as competitor Nikola (NKLA) inked a strategic partnership with General Motors (GM). The Nasdaq sank 4% on the day.

“The sell-off in risky assets has been concentrated in US Tech and momentum stocks, while credit has been more resilient and outperformed its beta to equity,” according to a note from Goldman Sachs strategists over the weekend. “This is likely due to the unwinding of some of the popular positions into the largest US stocks. In fact, the US equity rally has been very concentrated so far with very low breadth.”

“While aggregate US equity future net length is not very stretched, Nasdaq net equity future positioning is close to historical highs,” the analysts said. They added that an increase in the 10-year Treasury yield off the pandemic-era lows also likely triggered a rotation out of longer-duration stocks, including growth and tech names.

Still, the analysts added they “expect the current bull market to continue as the improved growth outlook coupled with supportive monetary policies should maintain the search for yield elevated and foster a compression of the ERPs [equity risk premiums].”

Elsewhere, investors eyed developments on the Covid-19 vaccine front. Tuesday morning, the CEOs of some of the pharmaceutical companies front-running the race toward creating on a vaccine wrote a public letter vowing to avoid cutting corners in the development process, even as they work with an expedited timeline to try and quickly distribute an inoculation.

“In the interest of public health, we pledge to always make the safety and well-being of vaccinated individuals our top priority,” according to the letter, signed by the CEOs of companies including AstraZeneca (AZN), Johnson & Johnson (JNJ) and Moderna (MRNA).

In news conference yesterday, President Donald Trump said he believed a Covid-19 vaccine could be approved as soon as October. Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases said seeing a vaccine receive approval by October was “unlikely” but “not impossible,” according to a recent interview with CNN.